The findings by scientist from the Scripps Research Institute (TRSI), the International AIDS Vaccine Initiative (IAVI) and the La Jolla Institute have shown that the precursor (germline) cells for one kind of HIV anti-body are present in most people infected with Human Immune-deficiency Virus (HIV).

The scientists are working together to develop an HIV vaccine germline-targeting immunogen capable of binding those B cells.

No Comments

Leave a Comment